MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2016 International Congress

    Chin EMG variance and dream-enactment behavior during polysomnography in Parkinson’s disease

    Y. Shen, K.P. Xiong, C.J. Mao, C.F. Liu (Suzhou, People's Republic of China)

    Objective: The aim of this study was to exam relationships between REM sleep muscle atonia (RSWA), dream-enactment behavior(DEB) and clinical characteristics in Parkinson's disease (PD)…
  • 2016 International Congress

    Risks and predictive factors for pneumonia amongst Parkinson’s disease patients with dysphagia

    K.H. Goh, H.L. Ng, K.Y. Tay, S. Acharyya, S.Y.E. Ng, J.P.L. Boo, A.H.J. Kooi, W. Li, W.L. Au, L.C.S. Tan (Singapore, Singapore)

    Objective: To evaluate (1) Time to hospitalisation for pneumonia/choking in Parkinson's disease (PD) patients. (2) Demographic and clinical features that associated with pneumonia/choking. Background: Dysphagia…
  • 2016 International Congress

    Quality of life after subthalamic stimulation depends on non-motor symptoms in Parkinson’s disease

    H.S. Dafsari, L. Weiss, M. Silverdale, P. Reddy, A. Rizos, M. Samuel, E. Perrier, J. Evans, K. Ashkan, J.N. Petry-Schmelzer, V. Visser-Vandewalle, A. Antonini, P. Martinez-Martin, K.R. Chaudhuri, L. Timmermann (Cologne, Germany)

    Objective: To investigate non-motor symptoms (NMS) to find contributing factors for quality of life (QoL) outcome after subthalamic nucleus (STN) deep brain stimulation (DBS) in…
  • 2016 International Congress

    Associated and predictive factors of depressive symptoms in patients with Parkinson’s disease

    K. Zhu, J.J. Van Hilten, J. Marinus (Leiden, Netherlands)

    Objective: The aim of this longitudinal study is to examine which variables are associated with depressive symptoms in Parkinson's disease (PD), as well as to…
  • 2016 International Congress

    Clinical and biological predictors of excessive daytime sleepiness in early Parkinson’s disease

    T. Simuni, J. Long, C. Caspell-Garcia, C.S. Coffey, W. Oertel, S. Lasch, K. Marek, On behalf of the PPMI Sleep Working Group (Chicago, IL, USA)

    Objective: To examine longitudinal change in excessive daytime sleepiness (EDS) and to determine clinical and biological variables that predict new onset EDS in the cohort…
  • 2016 International Congress

    Non-motor symptoms in advanced Parkinson’s disease patients treated with levodopa/carbidopa intestinal gel, deep brain stimulation, or continuous subcutaneous apomorphine: A systematic literature review and pooled analysis

    K.R. Chaudhuri, E. Terasawa, Y. Jalundhwala, D. Macaulay, R. Ayyagari, Z.Y. Zhou, T. Marshall, K. Chatamra, A. Yucel, K. Sail (London, United Kingdom)

    Objective: To systematically review literature reporting changes in non-motor symptoms (NMS) among patients with advanced PD (APD) treated with levodopa/carbidopa intestinal gel (LCIG), deep brain…
  • 2016 International Congress

    The impact of a movement disorders specialist on resident knowledge, as measured by the resident in-service training examination (RITE)

    A. Killoran (Morgantown, WV, USA)

    Objective: To determine a movement disorders specialist's impact on resident education, as assessed by the Resident In-Service Training Examination (RITE) scores. Background: Neurology resident knowledge…
  • 2016 International Congress

    Demographic feature and clinical characteristic of patients with Parkinson’s disease in Isfahan, Iran

    M. Salari (Isfahan, Islamic Republic of Iran)

    Objective: To evaluated demographic and clinical characteristic feature of patients with Parkinson's disease in Isfahan city in Iran. Background: Parkinson's disease (PD) is one of…
  • 2016 International Congress

    Ethnic differences in rates of Parkinson’s in New Zealand: A nation-wide prevalence and incidence study

    T.L. Pitcher, D.J. Myall, M.R. MacAskill, J.F. Pearson, C.J. Lacey, J.C. Dalrymple-Alford, T.J. Anderson (Christchurch, New Zealand)

    Objective: To estimate the prevalence and incidence of Parkinson's in New Zealand and to investigate if these measures differ between the major ethnic groups represented…
  • 2016 International Congress

    Predicting poor functional outcome in Parkinson’s disease

    A.D. Macleod, C.E. Counsell (Aberdeen, United Kingdom)

    Objective: We aimed to describe progression to, identify independent prognostic factors for, and develop a valid prognostic model for, dependency and “death or dependency” in…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • …
  • 207
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • #24752 (not found)
  • An atypical and interesting feature of Parkinson´s disease
  • Fasciculations from a cholinesterase inhibitor
  • Patients with Essential Tremor Live Longer than their Relatives
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley